Form 4: Bristol Myers Squibb Director Reports Stock Transactions

Bristol Myers Squibb Director Derica W. Rice reported transactions involving deferred share units.

Summary

• Derica W. Rice, a Director at Bristol Myers Squibb Company, has filed a Form 4 statement detailing changes in beneficial ownership.
• The filing indicates the acquisition of 672.51 Deferred Share Units on June 30, 2026.
• These Deferred Share Units are convertible into shares of common stock upon settlement, which occurs when the reporting person ceases to be a director or at a previously specified future date.
• The filing also notes that the ownership figure includes deferred compensation and reinvested dividends under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine disclosure of director stock unit transactions rather than significant strategic or financial news.

Positives

• Director Rice's continued participation and reporting of transactions suggest ongoing engagement with the company.
• The inclusion of deferred compensation and reinvested dividends indicates a long-term incentive structure for directors.

Risks

• The settlement of Deferred Share Units is contingent on the reporting person ceasing to be a director or a future specified date, introducing timing uncertainty for the conversion into common stock.

Future Outlook

The future outlook for the reported transactions is tied to the settlement of Deferred Share Units, which will occur upon the reporting person's departure from the board or a predetermined future date, at which point they will convert into common stock.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the pharmaceutical and biotechnology sectors, providing transparency on executive and director holdings and activities.

Stakeholder Impact

• Shareholders: Increased transparency regarding director holdings and potential future dilution upon settlement of units.
• Directors: Continued participation in long-term incentive plans through deferred compensation and dividend reinvestment.

Next Steps

• Settlement of Deferred Share Units upon reporting person's cessation as director or at a specified future date.
• Conversion of Deferred Share Units into shares of common stock.

Key Dates

Keywords

Bristol Myers Squibb, Form 4, SEC Filing, Insider Trading, Director Transactions, Deferred Share Units, Beneficial Ownership, BMY